(Q41719808)

8 October 2017

title

Elevated substance-P-like immunoreactivity levels in spinal dialysates during the formalin test in normal and diabetic rats (English)

1 reference

8 October 2017

Calcutt NA

1

1 reference

8 October 2017

Stiller C

series ordinal

2

1 reference

8 October 2017

Gustafsson H

series ordinal

3

1 reference

8 October 2017

Malmberg AB

series ordinal

4

1 reference

8 October 2017

publication date

1 February 2000

1 reference

8 October 2017

1 reference

8 October 2017

volume

856

1 reference

8 October 2017

issue

1-2

1 reference

8 October 2017

page(s)

20-27

1 reference

The non‐peptide NK1 receptor antagonist, (±)‐CP‐96,345, produces antinociceptive and anti‐oedema effects in the rat

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Tachykinin multiplicity in rat central nervous system as studied using antisera raised against substance P and neurokinin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

In vivo release of substance P in cat dorsal horn studied with microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Multiple molecular forms of tachykinins in rat spinal cord: a study comparing different extraction methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Primary afferent tachykinins are required to experience moderate to intense pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Effects of diabetes on tissue content and evoked release of calcitonin gene-related peptide-like immunoreactivity from rat sensory nerves

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Different effects of two aldose reductase inhibitors on nociception and prostaglandin E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Tolrestat treatment prevents modification of the formalin test model of prolonged pain in hyperglycemic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Axonal transport of substance P-like immunoreactivity in ganglioside-treated diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

The effect of intrathecal administration of RP67580, a potent neurokinin 1 antagonist on nociceptive transmission in the rat spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Altered nociception, analgesia and aggression in mice lacking the receptor for substance P

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Expression of neuropeptides in experimental diabetes; effects of treatment with nerve growth factor or brain-derived neurotrophic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Depletion of substance P and calcitonin gene-related peptide in sciatic nerve of rats with experimental diabetes; effects of insulin and aldose reductase inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Denervation and hyperinnervation in the nervous system of diabetic animals. II. Monoaminergic and peptidergic alterations in the diabetic encephalopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Reduced neurogenic inflammation in streptozotocin-diabetic rats due to microvascular changes but not to substance P depletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Pharmacological properties of a potent and selective nonpeptide substance P antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

alpha-Lipoic acid corrects neuropeptide deficits in diabetic rats via induction of trophic support

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Synthesis, and central and peripheral axonal transport of substance P in a dorsal root ganglion-nerve preparation in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: enkephalin and substance P.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Changes of substance P-like immunoreactivity in the dorsal horn are associated with the ‘phasic’ behavioral response to a formalin stimulus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Neonatal capsaicin treatment abolishes formalin-induced spinal PGE2 release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Spinal neurokinin NK1 receptor down-regulation and antinociception: effects of spinal NK1 receptor antisense oligonucleotides and NK1 receptor occupancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Development of supersensitivity to substance P in the spinal cord of the streptozotocin-induced diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Alterations in the potassium-evoked release of substance P from the spinal cord of streptozotocin-induced diabetic rats in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Increase in substance P in the dorsal horn during a chemogenic nociceptive stimulus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Stimulus specificity of peripherally evoked substance P release from the rabbit dorsal horn in situ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Influence of diabetes upon the inflammatory response of the rat. A pharmacological analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Nerve growth factor treatment increases stimulus-evoked release of sensory neuropeptides in the rat spinal cord

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Cyclooxygenase inhibition and the spinal release of prostaglandin E2 and amino acids evoked by paw formalin injection: a microdialysis study in unanesthetized rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Anti-nociceptive effects of the GM1 ganglioside derivative AGF 44 on the formalin test in normal and streptozotocin-diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

The spinal loop dialysis catheter: characterization of use in the unanesthetized rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Altered vascular permeability responses to substance P in diabetic rats: interactions with a nitric oxide synthesis inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Ultrastructural visualization of glutamate and aspartate immunoreactivities in the rat dorsal horn, with special reference to the co-localization of glutamate, substance P and calcitonin-gene related peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Release of substance P-like immunoreactivity from isolated spinal cord of newborn rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Edinger-Westphal neurons that project to spinal cord contain substance P

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Enantioselective inhibition of the formalin paw late phase by the NK1 receptor antagonist L-733,060 in gerbils.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Antinociceptive effects in the formalin and capsaicin tests after intrathecal administration of substance P analogues in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

The neurokinin-1 receptor antagonist, sendide, exhibits antinociceptive activity in the formalin test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Responses of functionally identified neurones in the dorsal horn of the cat spinal cord to substance P, neurokinin A and physalaemin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

The spinal contribution of substance P to the generation and maintenance of inflammatory hyperalgesia in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Cerebrospinal fluid levels of substance P and calcitonin-gene-related peptide: correlation with sural nerve levels and neuropathic signs in sensory diabetic polyneuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: Antinociception in the absence of motor dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Substance P reduces tail-flick latency: implications for chronic pain syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2902345-8

10.1016/S0006-8993(99)02345-8

7 January 2021

Identifiers

DOI

1 reference

8 October 2017

1 reference